Published in Diabetes Obes Metab on December 16, 2013
Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study. Medicine (Baltimore) (2016) 0.92
Slowing ageing by design: the rise of NAD(+) and sirtuin-activating compounds. Nat Rev Mol Cell Biol (2016) 0.86
Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults. Colomb Med (Cali) (2016) 0.79
The role of empagliflozin in the management of type 2 diabetes by patient profile. Ther Clin Risk Manag (2015) 0.79
Empagliflozin/linagliptin single-tablet combination: first-in-class treatment option. Int J Clin Pract (2015) 0.76
Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients. Ther Clin Risk Manag (2014) 0.76
Supplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini Review. J Clin Transl Hepatol (2016) 0.75
Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes. Diabetes Care (2016) 0.75
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. Diabetes Obes Metab (2010) 2.30
Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation. Int J Clin Pract (2011) 2.25
Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes. Diabetes Obes Metab (2008) 1.68
The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial. Int J Clin Pract (2011) 1.47
Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis. Diabet Med (2013) 1.23
Time to treatment initiation with oral antihyperglycaemic therapy in US patients with newly diagnosed type 2 diabetes. Diabetes Obes Metab (2011) 0.95
Improving diabetic retinopathy screening through a statewide telemedicine program at a large federally qualified health center. J Health Care Poor Underserved (2011) 0.94
Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes. Diabetes Obes Metab (2011) 0.89
Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Diabetes Obes Metab (2015) 0.87
Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes. Int J Clin Pract (2011) 0.85
Recent trends in the characteristics of patients prescribed sitagliptin and other oral antihyperglycaemic agents in a large U.S. claims database. Int J Clin Pract (2013) 0.83
Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation. Int J Clin Pract (2012) 0.83
Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk. Diabetes Obes Metab (2012) 0.82
The scope of practice of diabetes educators in a metropolitan area. Diabetes Educ (1992) 0.81
Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis. Int J Clin Pract (2013) 0.79
Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy. Diabetes Obes Metab (2011) 0.79
Dissemination of diabetes care guidelines: lessons learned from community health centers. Diabetes Educ (2002) 0.77
Nutritional management for patients with diabetes. Conn Med (1991) 0.75
Diabetes. Conn Med (1991) 0.75
Long-term efficacy of sitagliptin as either monotherapy or add-on therapy to metformin: improvement in glycemic control over 2 years in patients with type 2 diabetes. Curr Med Res Opin (2015) 0.75